Auzzas L; Larsson A; Matera R; Baraldi A; Deschenes-Simard B; Giannini G; Cabri W; Battistuzzi G; Gallo G; Ciacci A; Vesci L; Pisano C; Hanessian S, Non-Natural Macrocyclic Inhibitors of Histone Deacetylases: Design, Synthesis, and Activity, «JOURNAL OF MEDICINAL CHEMISTRY», 2010, 53, pp. 8387 - 8399 [Comment or similar]
Patent n. US9133197, OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS.
Cabri w, Present and Future of Industrial Pharmaceutical Industries in Italy, «LA CHIMICA E L'INDUSTRIA», 2010, 76, pp. 84 - 85 [Scientific article]
D'Acquarica I; Gasparrini F; Kotoni D; Pierini M; Villani C; Cabri W; Di Mattia M; Giorgi F, Stereodynamic Investigation of Labile Stereogenic Centres in Dihydroartemisinin, «MOLECULES», 2010, 15, pp. 1309 - 1323 [Scientific article]
I. D'Aquarica; F.Gasparrini; D.Kotoni; M.Pierini; M.Piras; C.Villani;W.Cabri;M.Di Mattia; F.Giorgi; A.Mazzanti, Stereolability of MKA, a rearrangement product of dihydroartemisinin endowed with antimalarian activity, in: AA.VV., Atti del Convegno, ROMA, Società Chimica Italiana, 2010, 1, pp. P93 - P93 (atti di: XXXIII Convegno Nazionale della Divisione di Chimica Organica, S.Benedetto del Tronto, 12-16 settembre 2010) [Abstract]
Patent n. US7799921, Stereoselective process and crystalline forms of a camptothecin.
Patent n. US81247769, Stereoselective process and crystalline forms of a camptothecin.
Hanessian S; Auzzas L; Larsson A; Zhang JB; Giannini G; Gallo G; Ciacci A; Cabri W, Vorinostat-Like Molecules as Structural, Stereochemical, and Pharmacological Tools, «ACS MEDICINAL CHEMISTRY LETTERS», 2010, 1, pp. 70 - 74 [Scientific article]
Patent n. US8383616, Aryl isoxazole compounds with antitumoral Activities.
P. Galletti; A. Quintavalla; C. Ventrici; G. Giannini; W. Cabri; S. Penco; G. Gallo; S. Vincenti; D. Giacomini, Azetidinones as Zinc-Binding Groups to Design Selective HDAC8 Inhibitors, «CHEMMEDCHEM», 2009, 4, pp. 1991 - 2001 [Scientific article]
Cabri W, Catalysis: The pharmaceutical perspective, «CATALYSIS TODAY», 2009, 140, pp. 2 - 10 [Comment or similar]
Giannini G.; Marzi M.; Pezzi R.; Brunetti T.; Battistuzzi G.; Marzo M.D.; Cabri W.; Vesci L.; Pisano C., Corrigendum to "N-Hydroxy-(4-oxime)-cinnamide: A versatile scaffold for the synthesis of novel histone deacetilase (HDAC) inhibitors" [Bioorg. Med. Chem. Lett. 19 (2009) 2346] (DOI:10.1016/j.bmcl.2009.02.029), «BIOORGANIC & MEDICINAL CHEMISTRY LETTERS», 2009, 19, pp. 3694 - 3694 [Scientific article]
Patent n. US8865597, Crystalline(6R,7R)-7-[1,2,4]triazolo-3-yl)-2-[(Z)-trityloxyimino]-acety-lamino)- 3-[(R)-1’-tert-butoxycarbonyl-2-oxo-[1,3’]bipyrrolidinyl-(3E)ylidenemethyl-8-oxo- 5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydril ester; its manufacturing and use.
Patent n. WO2009109504, Enol carbamate derivatives as modulators of fatty Acid Amide Hydrolase.
Giannini G; Marzi M; Di Marzo M; Battistuzzi G; Pezzi R; Brunetti T; Cabri W; Vesci L; Pisano C, Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors, «BIOORGANIC & MEDICINAL CHEMISTRY LETTERS», 2009, 19, pp. 2840 - 2843 [Scientific article]
